Scott Huennekens

About Scott Huennekens

Scott Huennekens is President and CEO of Volcano Therapeutics. Scott Huennekens has served as our President and Chief Executive Officer and as a member of our board of directors since April 2002. From January 2000 to March 2002, Mr. Huennekens served as the President and Chief Executive Officer of Digirad Corporation, a medical imaging company. Mr. Huennekens holds a B.S. in Business Administration from the University of Southern California and an M.B.A. from Harvard University.

Quotes

1. “ We continued to drive growth in both our intravascular ultrasound (IVUS) and Functional Measurement (FM) businesses, which grew 25 and 51 percent year-over-year, respectively. In the quarter, overall IVUS disposable revenues increased 29 percent versus the prior year, and our FM business increased 50 percent in both the U.S. and Europe...During the quarter, we introduced significant enhancements to our IVUS and FM disposables and our multi-modality console operating software, and commenced the European launch of our VIBE RX Vascular Imaging Catheter. In addition, we completed a number of cases utilizing the latest version of our Optical Coherence Tomography (OCT) catheter and system. ”

   In Volcano Reports Record Quarterly Revenues and Profitability; Year-to-Date Revenues Increase 36 Percent

2. “ We continued to drive growth in both our intravascular ultrasound (IVUS) and Functional Measurement (FM) businesses, which grew 25 and 51 percent year-over-year, respectively. In the quarter, overall IVUS disposable revenues increased 29 percent versus the prior year, and our FM business increased 50 percent in both the U.S. and Europe...During the quarter, we introduced significant enhancements to our IVUS and FM disposables and our multi-modality console operating software, and commenced the European launch of our VIBE RX Vascular Imaging Catheter. In addition, we completed a number of cases utilizing the latest version of our Optical Coherence Tomography (OCT) catheter and system. ”

   In Volcano Reports Record Quarterly Revenues and Profitability; Year-to-Date Revenues Increase 36 Percent

3. “ St. Jude Medical's acquisition of LightLab confirms the validity and potential utility of this leading edge technology...We are planning a best-in-class OCT solution. We currently have CE Mark in Europe on our first generation platform, and we are targeting a release of our second generation platform in Europe early next year. We anticipate that this system will incorporate a smaller catheter, shorter prep time, faster pullback speed, and a longer imaging segment than the current device. ”

   In Volcano Announces Positive Clinical Experience With Its Second Generation OCT Catheter, Prepares for U.S. Regulatory Study

4. “ We continued to execute on our growth strategies by increasing the installed base of our multi-modality platforms and generating increased market share and utilization for our offerings...Key drivers of our year-over-year growth included a 58 percent increase in intravascular ultrasound (IVUS) disposable revenues in Japan, 46 percent growth in our U.S. functional measurement (FM) disposable sales and increased market penetration in Europe, where IVUS and FM disposable revenues increased 32 percent and 92 percent, respectively. ”

   In Volcano Reports 36 Percent Increase in First Quarter Revenues

5. “ Our technology innovation, market development, clinical and product initiatives have fueled our growth during 2009 and leave us well positioned for a strong 2010 marked by excellent revenue growth and GAAP profitability. ”

   In Volcano Reports 44 Percent Increase in Fourth Quarter Revenues

6. “ Volcano is excited to fortify its commitment to be the leading and most-trusted partner for physicians when addressing patients with complex disease states that require thrombus aspiration. ”

   In Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract Thrombus Aspiration Catheter

7. “ Reaching this milestone as quickly as we have is a clear demonstration of the strong demand for our diverse PCI guidance technology....Despite the challenging healthcare and economic environment in the U.S., Volcano has placed more systems in the past 12 months than at anytime in our history, and by our estimate, capturing more than 70% of all new IVUS systems placed in U.S. hospitals during this period. ”

   In Volcano Announces Installed Base Growth Milestone

8. “ In addition to experiencing a very solid financial performance during the quarter, we completed our transition from our distributor relationship with Goodman to a direct sales effort in Japan and had new data demonstrating the value of our offerings presented at the recent Transcatheter Cardiovascular Therapeutics (TCT) meeting. ”

   In Volcano Reports 22 Percent Increase in Third Quarter Revenues

9. “ Angiography alone is not enough and more and more clinical data continues to support that conclusion. ”

   In Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks

10. “ Volcano had an excellent quarter with strong growth in our core intravascular ultrasound and functional measurement businesses. ”

    In Volcano cuts Q2 loss, revenue increases

1. Mentioned In 71 Articles

2. Volcano Corporation Presentation at Canaccord Genuity Growth Conference to be Webcast

   Explore Article PR Newswire (Aug 3 2010) Cardiology , Other Business News

   ...g in the 30th Annual Canaccord Genuity Growth Conference on Tuesday, August 10. The presentation by Scott Huennekens, president and chief executive officer, will begin at 9 a.m., Eastern Daylight Time (6 a.m., Pacifi... (Read Full Article)
   

   Comment on Article Mentions:   Axsun Technologies   Volcano   Scott Huennekens

3. Volcano Reports Record Quarterly Revenues and Profitability; Year-to-Date Revenues Increase 36 Percent

   Explore Article PR Newswire (Jul 30 2010) Cardiology , Other Business News

   ... versus the prior year, and our FM business increased 50 percent in both the U.S. and Europe," said Scott Huennekens, president and chief executive officer. "During the quarter, we introduced significant enhancem... (Read Full Article)
   

   Comment on Article Mentions:   Axsun Technologies   Volcano   Scott Huennekens

4. Volcano Corporation Schedules Second Quarter Conference Call, Webcast

   Explore Article ptca.org (Jul 20 2010) Cardiology , Other Business News

   ... at 5:30 a.m., Pacific Daylight Time (8:30 a.m., Eastern Daylight Time), Friday, July 30, hosted by Scott Huennekens, president and chief executive officer, and John Dahldorf, chief financial officer. The teleconfere... (Read Full Article)
   

   Comment on Article Mentions:   Volcano   John Dahldorf   Scott Huennekens

5. Volcano Introduces Vibe™ Rx - the World's Only Vascular Imaging Balloon Catheter

   Explore Article PR Newswire (May 26 2010) Cardiology , Other Business News , Probes

   ...vices designed to allow physicians to see more detail right at the point of the therapy," commented Scott Huennekens, President and Chief Executive Officer of Volcano. "Although our initial focus is on cardiovascular... (Read Full Article)
   

   Comment on Article Mentions:   John A. Ormiston   Scott Huennekens   Volcano

6. Volcano Announces Positive Clinical Experience With Its Second Generation OCT Catheter, Prepares for U.S. Regulatory Study

   Explore Article PR Newswire (May 20 2010) Cardiology , Other Business News

   ...tion of LightLab confirms the validity and potential utility of this leading edge technology," said Scott Huennekens, President and Chief Executive Officer of Volcano. "We are planning a best-in-class OCT solution. W... (Read Full Article)
   

   Comment on Article Mentions:   LightLab Imaging   Volcano   Michel Lussier

7. Volcano Announces 510(k) Clearance, CE Mark Approval, and First Clinical Use for the PrimeWire Prestige(tm) Pressure Guide Wire

   Explore Article PR Newswire (May 19 2010) Cardiology , Other Business News

   ...nderline our commitment to delivering innovation and choice to our customers and patients," said Scott Huennekens, President and CEO of Volcano Corporation. "Our goal is to provide simple, easy-to-use products th... (Read Full Article)
   

   Comment on Article Mentions:   GE Healthcare   University of Arizona   Volcano

8. Volcano Corporation Presentation at Bank of America Merrill Lynch Health Care Conference to Be Webcast

   Explore Article ptca.org (May 5 2010) Cardiology , Other Business News

   ...he Bank of America Merrill Lynch Health Care Conference on Tuesday, May 11. The presentation by Scott Huennekens, president and chief executive officer, will begin at 9:20 a.m., Eastern Daylight Time (6:20 a.m., ... (Read Full Article)
   

   Comment on Article Mentions:   Volcano   Scott Huennekens

9. Volcano Reports 36 Percent Increase in First Quarter Revenues

   Explore Article PR Newswire (May 3 2010) Cardiology , Other Business News

   ...i-modality platforms and generating increased market share and utilization for our offerings," said Scott Huennekens, president and chief executive officer. "Key drivers of our year-over-year growth included a 58 per... (Read Full Article)
   

   Comment on Article Mentions:   Volcano   Scott Huennekens

10. Volcano Announces Distribution Agreement With AngioScore for the AngioSculpt(R) PTCA Scoring Balloon Catheter in Japan

    Explore Article PR Newswire (Apr 27 2010) Cardiology , Other Business News

    ...han 50 direct sales representatives. "Not every lesion or heart blockage is the same," commented Scott Huennekens, President and CEO of Volcano. "Physicians have to make a number of difficult decisions as they bui... (Read Full Article)
    

    Comment on Article Mentions:   Volcano   Scott Huennekens

11. Volcano Corporation Schedules First Quarter Conference Call, Webcast

    Explore Article PR Newswire (Apr 26 2010) Cardiology , Other Business News

    ...parties at 2 p.m., Pacific Daylight Time, (5 p.m., Eastern Daylight Time), Monday, May 3, hosted by Scott Huennekens, president and chief executive officer, and John Dahldorf, chief financial officer. The telecon... (Read Full Article)
    

    Comment on Article Mentions:   Volcano   John Dahldorf   Scott Huennekens

12. Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systems

    Explore Article money.cnn.com (Mar 12 2010) Cardiology , Other Business News

    ...levation of the level of evidence for FFR in the ACC/AHA/SCAI PCI Guidelines to Level A," commented Scott Huennekens, President and CEO of Volcano. "The FAME study demonstrated a 34% reduction in death and myocardial... (Read Full Article)
    

    Comment on Article Mentions:   GE Healthcare   Siemens   Volcano

13. Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systems

    Explore Article PR Newswire (Mar 12 2010) Cardiology , Other Business News

    ...levation of the level of evidence for FFR in the ACC/AHA/SCAI PCI Guidelines to Level A," commented Scott Huennekens, President and CEO of Volcano. "The FAME study demonstrated a 34% reduction in death and myocardial... (Read Full Article)
    

    Comment on Article Mentions:   GE Healthcare   Siemens   Volcano

14. Volcano Reports 44 Percent Increase in Fourth Quarter Revenues

    Explore Article PR Newswire (Mar 3 2010) Cardiology , Other Business News

    ... Japan as IVUS disposable revenues increased 43 percent versus the fourth quarter a year ago," said Scott Huennekens, president and chief executive officer. Huennekens noted that despite a challenging capital equipme... (Read Full Article)
    

    Comment on Article Mentions:   Axsun Technologies   Volcano   Scott Huennekens

15. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast

    Explore Article PR Newswire (Feb 24 2010) Cardiology , Other Business News

    ...es at 2 p.m., Pacific Standard Time, (5 p.m., Eastern Standard Time), Wednesday, March 3, hosted by Scott Huennekens, president and chief executive officer, and John Dahldorf, chief financial officer. Volcano Corpora... (Read Full Article)
    

    Comment on Article Mentions:   Volcano   John Dahldorf   Scott Huennekens

16. Volcano Receives FDA Clearance to Market the Eagle Eye(R) Platinum Digital IVUS Catheter

    Explore Article PR Newswire (Feb 9 2010) Cardiology , Other Business News

    ...he second quarter of 2010. "Multiple studies have shown the benefits of IVUS imaging," commented Scott Huennekens, President and Chief Executive Officer of Volcano. "With Eagle Eye® Platinum, we're now providing c... (Read Full Article)
    

    Comment on Article Mentions:   Volcano   FDA   Scott Huennekens

1-15 of 71 // 1 2 3 4 5 »